Current location - Trademark Inquiry Complete Network - Trademark registration - Yatai Group’s 2020 Semi-annual Board of Directors Operation Review
Yatai Group’s 2020 Semi-annual Board of Directors Operation Review

Yatai Group (600881)’s 2020 semi-annual board of directors operating review contains the following content:

1. Discussion and analysis of operating conditions

During the reporting period, the following aspects In response to the sudden COVID-19 epidemic and the complex and ever-changing domestic and international economic environment, the company's operation and management teams at all levels, under the leadership of the board of directors, adhered to the operating policy of "fighting the epidemic and focusing on operations" and immediately organized all employees to go all out to fight against the epidemic. In response to the epidemic, we donated money and materials while actively promoting the resumption of work and production, and the company's operations were running smoothly.

The building materials industry is based on the principle of maximizing market share and production capacity utilization, closely integrating the upstream and downstream industries, giving full play to the advantages of the building materials group's industrial chain and marketing team, adopting a flexible approach, maximizing the development of end customers, and giving full play to Asia's Tai Commercial Concrete Enterprise, Yatai Commercial Concrete Cooperation Station, and Yatai Cement’s key customer layout advantages have boosted cement sales by increasing commercial concrete customer development and improved overall market control.

The pharmaceutical industry adheres to the innovation-driven development strategy, vigorously promotes industrial upgrading and model innovation, realizes the transformation from pharmaceutical services to health management, and creates a comprehensive health industry with core competitiveness, brand leadership, and radiation to the three northeastern provinces. Cluster, key research and development projects such as Vicagrelor, Forsythin, H5N1 human avian influenza vaccine (Vero cells), and MDCK cell seasonal influenza vaccines are advancing in an orderly manner.

The real estate industry takes "accelerating the sales pace, quickly withdrawing funds, and developing advantageous areas" as its operational core, and "optimizing marketing expenses, innovating marketing mechanisms, and improving service standards" as its management focus to increase marketing wisdom. Investment, execution investment, and standardization investment, actively carry out "property +" special services, focus on organizing and deploying epidemic prevention and anti-disease work, shoulder social responsibilities, maintain the real estate brand, and promote the healthy development of the industry.

During the reporting period, the company achieved operating income of RMB 8,334,607,900, operating profit of RMB 81,655,600, and net profit attributable to shareholders of the listed company of RMB 122,929,100.

2. Possible risks

1. Excess production capacity of building materials

During the reporting period, the country continued to deepen supply-side structural reform policies, and the cement industry production capacity The oversupply conflict has not been fundamentally resolved. The Northeast region has overcapacity and low capacity utilization, which has restricted the efficiency of cement companies in the Northeast region and the high-quality development of the cement industry.

2. Risks of new drug research and development

New drug research and development is characterized by high investment, high technology, high risk, and long time. Due to the rapid update of new drug review and regulatory policies, new drug research and development The continuous improvement of review standards, the complexity of the research and development process, the uncertainty of approval results and other reasons, as well as the impact of new drugs on the market by objective factors such as industry policies and market environment, bring certain risks to the company's new drug research and development.

3. Real estate capital risks

The real estate development industry is a capital-intensive industry. Affected by the macroeconomic situation and financing environment, real estate companies have faced financing difficulties in recent years. Affected by the COVID-19 epidemic, project development and sales collection cycles have been extended, and the cash flow of real estate companies will continue to be under pressure in the future.

Measures: The company will further improve the sensitivity of macro policies and the real estate industry, actively study and judge the market and policy situation, actively innovate marketing methods, seize market opportunities, seize sales to promote repayment, and accelerate inventory removal. ization, revitalize existing assets, and effectively improve capital turnover and utilization.

3. Analysis of core competitiveness during the reporting period

Building materials industry: The building materials industry has complete upstream and downstream industrial chain advantages, resource advantages (possessing high-quality resources such as coal and mines) and brand Advantages. Based in Changchun, Shenyang, Harbin, and Dalian, we have built 4 industrial parks for construction industrial products. The products cover six categories: large infrastructure components, industrial residential components, public building components, industrial building components, municipal landscape, and water conservancy components. The scale ranks first among the three northeastern provinces.

It has well-known Chinese trademarks such as "Jindinglu", "Dinglu" and "Swan" and well-known regional brands such as "Shanquan", "Longtanshan", "Tiexin" and "Jianba", and has a sales network Radiating to three provinces and one region in Northeast China.

Pharmaceutical industry: The pharmaceutical industry insists on promoting scientific and technological innovation. The national first-class cardiovascular and cerebrovascular new drug Vicagrelor has completed Phase II clinical trials. The research and development of new human avian influenza H5N1 whole virus inactivated vaccine (Vero cells) and MDCK seasonal influenza vaccine are progressing in an orderly manner. Vigorously expand the three major marketing networks of clinical academic promotion, large and medium-sized retail chain terminals, and primary medical terminals, forming a network layout that radiates Northeast and North China. Jilin Pharmacy Pharmaceutical Co., Ltd. is ranked 12th in the country and 1st in Jilin Province. A pharmaceutical chain enterprise, Beijing Yatai Yongantang Pharmaceutical Co., Ltd. owns the "Yongantang" brand, a time-honored Chinese brand with a history of more than 600 years. Based on the brand, it creates "Yongantang" brand leading pills, traditional Chinese medicine pieces, ginseng antong and ginseng. series of products.

Real estate industry: The real estate industry focuses on the development positioning of "ecology, cultural tourism, and health care", and takes "national layout, large-scale development, and integrated development" as its strategic layout to form a collection of land consolidation, real estate A complete industrial chain integrating development, residential industrial design, construction, decoration engineering, environmental engineering and property services; on the basis of developing high-quality ecological health-preserving residences, we will actively leverage the advantages of the industrial chain, develop a multi-format product system, and promote The industry continues to develop healthily.